Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Greig

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Transplantation Proceedings|March 27, 2001
Natural history of recurrent hepatitis C after liver transplantationG Malkan, A Humar, L Lilly, et al.
Transplantation Proceedings|September 2, 1998
Outcome of kidney transplantation alone versus synchronous pancreas-kidney transplantation in type 1 diabeticsM S Cattral, A W Hemming, P D Greig, et al.
Transplantation Proceedings|September 2, 1998
Low incidence of rejection after synchronous pancreas-kidney transplantation with NeoralM S Cattral, A W Hemming, P D Greig, et al.
Anesthesiology|November 1, 1996
Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantationJ F Boylan, J R Klinck, A N Sandler, et al.
Transplantation|May 26, 1999
Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantationM S Cattral, A W Hemming, I R Wanless, et al.
The Journal of Clinical Investigation|October 1, 1989
Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary reportS B Sinclair, P D Greig, L M Blendis, et al.
Transplantation|July 27, 1994
Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantationM Flowers, A Sherker, S B Sinclair, et al.
Annals of Surgery|November 7, 2000
Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipientsM S Cattral, D L Bigam, A W Hemming, et al.
Transplantation Proceedings|February 1, 1997
Long-term ribavirin therapy for recurrent hepatitis C after liver transplantationA A Aljumah, M S Cattral, P D Greig, et al.
Transplantation Proceedings|February 1, 1989
Antilymphoblast globulin (ALG) as initial prophylaxis against rejection following liver transplantationP D Greig, G Levy, R A Superina, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Transplantation Proceedings|March 27, 2001
Natural history of recurrent hepatitis C after liver transplantationG Malkan, A Humar, L Lilly, et al.
Transplantation Proceedings|September 2, 1998
Outcome of kidney transplantation alone versus synchronous pancreas-kidney transplantation in type 1 diabeticsM S Cattral, A W Hemming, P D Greig, et al.
Transplantation Proceedings|September 2, 1998
Low incidence of rejection after synchronous pancreas-kidney transplantation with NeoralM S Cattral, A W Hemming, P D Greig, et al.
Anesthesiology|November 1, 1996
Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantationJ F Boylan, J R Klinck, A N Sandler, et al.
Transplantation|May 26, 1999
Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantationM S Cattral, A W Hemming, I R Wanless, et al.
The Journal of Clinical Investigation|October 1, 1989
Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary reportS B Sinclair, P D Greig, L M Blendis, et al.
Transplantation|July 27, 1994
Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantationM Flowers, A Sherker, S B Sinclair, et al.
Annals of Surgery|November 7, 2000
Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipientsM S Cattral, D L Bigam, A W Hemming, et al.
Transplantation Proceedings|February 1, 1997
Long-term ribavirin therapy for recurrent hepatitis C after liver transplantationA A Aljumah, M S Cattral, P D Greig, et al.
Transplantation Proceedings|February 1, 1989
Antilymphoblast globulin (ALG) as initial prophylaxis against rejection following liver transplantationP D Greig, G Levy, R A Superina, et al.
Pageof 11